The University of Washington training program in the Molecular Pharmacology of Abused Drugs is designed to provide a cohesive training environment for 4 predoctoral and 2 postdoctoral fellows per year, interested in the molecular, cellular and behavioral pharmacological aspects of opioid, cannabinoid, and psychostimulant drug action. The program emphasizes training in research skills along with career development professional skills and responsible conduct of research-ethical skills. Faculty mentors provide training in a broad range of research approaches including molecular pharmacology, electrophysiology, neurochemistry, mouse genetics, viral-based gene expression and behavioral pharmacology. In addition to the general, ongoing training typical at this vibrant institution, trainees in this program experience a coordinated series of events specifically designed for their benefit including: invited speaker seminar sessions featuring internationally respected drug abuse researchers;monthly research progress meetings featuring local experts in abused drug research;weekly journal clubs on the current literature of opioid, cannabinoid and psychostimulant research;frequent opportunities for the trainees to enhance their presentation skills;courses organized for them on the 'Molecular Basis of Addiction1 and 'Addiction: Mechanisms, Treatment, Prevention1;and career development seminars designed to strengthen their scientific and professional foundations. Faculty mentors are highly collaborative, and trainees benefit from a strongly interactive, multidisciplinary research program. The training program will continue to be a catalyst for research collaborations among the participating labs, for technology transfer between labs, and for newly funded collaborative NIDA-grants. The trainees are drawn from an outstanding pool of candidates recruited to the participating graduate programs in pharmacology and neurobiology and to the well-respected laboratories as post-doctoral fellows. We have an active outreach program designed to encourage participation of underrepresented minorities and fellows from disadvantaged backgrounds. We actively train our students and fellows in responsible conduct of research and ethical treatment of animal subjects. The program is proud of its 15-year history of success in training fellows who have gone on to very successful scientific careers.

Public Health Relevance

This training program is designed to give its predoctoral and postdoctoral fellows essential skills in the study of the molecular basis of drug addiction. Trainees are expected to develop novel research projects that will provide important new insights to the addictive actions of drugs of abuse. These insights are expected to lead to new therapeutic tools for the treatment and prevention of drug addiction.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
5T32DA007278-20
Application #
8469448
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Babecki, Beth
Project Start
1993-08-01
Project End
2014-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
20
Fiscal Year
2013
Total Cost
$264,945
Indirect Cost
$17,781
Name
University of Washington
Department
Pharmacology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Lesiak, Adam J; Neumaier, John F (2016) RiboTag: Not Lost in Translation. Neuropsychopharmacology 41:374-6
Baker, Phillip M; Jhou, Thomas; Li, Bo et al. (2016) The Lateral Habenula Circuitry: Reward Processing and Cognitive Control. J Neurosci 36:11482-11488
Kuhar, Jamie Rose; Bedini, Andrea; Melief, Erica J et al. (2015) Mu opioid receptor stimulation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms. Cell Signal 27:1799-806
Fung, Susan; Cherry, Allison E; Xu, Cong et al. (2015) Alkylindole-sensitive receptors modulate microglial cell migration and proliferation. Glia 63:1797-808
Yager, L M; Garcia, A F; Wunsch, A M et al. (2015) The ins and outs of the striatum: role in drug addiction. Neuroscience 301:529-41
Ehrich, Jonathan M; Messinger, Daniel I; Knakal, Cerise R et al. (2015) Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons. J Neurosci 35:12917-31
Baker, Phillip M; Oh, Sujean E; Kidder, Kevan S et al. (2015) Ongoing behavioral state information signaled in the lateral habenula guides choice flexibility in freely moving rats. Front Behav Neurosci 9:295
Young, David L; Fields, Stanley (2015) The role of functional data in interpreting the effects of genetic variation. Mol Biol Cell 26:3904-8
Hart, Andrew S; Clark, Jeremy J; Phillips, Paul E M (2015) Dynamic shaping of dopamine signals during probabilistic Pavlovian conditioning. Neurobiol Learn Mem 117:84-92
Willuhn, Ingo; Burgeno, Lauren M; Groblewski, Peter A et al. (2014) Excessive cocaine use results from decreased phasic dopamine signaling in the striatum. Nat Neurosci 17:704-9

Showing the most recent 10 out of 60 publications